Defeating Multidrug Resistance: Innovations in Cancer Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 20 April 2025 | Viewed by 171
Special Issue Editor
Interests: multidrug resistance; hematology; lymphoma; astrobiology; sonoporation; electroporation
Special Issue Information
Dear Colleagues,
Multidrug resistance (MDR) remains a formidable obstacle in the fight against cancer, complicating the efficacy of therapies. This Special Issue, published in the International Journal of Molecular Sciences, seeks to explore the complex molecular mechanisms underlying drug resistance and the innovative strategies able to overcome these challenges. We welcome contributions that focus on the molecular interactions, genetic mutations, and cellular processes responsible for MDR in cancer cells. Although direct clinical studies are not suitable for submission to our journal, contributions that integrate clinical insights with biomolecular experiments are highly encouraged. This includes studies employing model systems or clinical samples to elucidate the molecular basis of the response and resistance of cells to cancer therapies. By focusing on the problems and solutions associated with multidrug resistance, this Special Issue aims to advance our understanding and development of more effective cancer treatments.
Dr. Dawid Przystupski
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- targeted cancer therapy
- multidrug resistance
- molecular mechanisms of cancer
- pharmacogenomics
- biomarkers in oncology
- personalized medicine
- cancer genomics
- therapeutic strategies
- liquid biopsy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
